Ipatasertib, an oral AKT inhibitor, effectively inhibits cell proliferation and migration, and induces apoptosis in endometrioid and serous endometrial cancer cell lines in vitro (Endometrial Cancer Molecularly Targeted Therapy Consortium)
Publication
, Conference
Buckingham, L; O'Donnell, J; Hao, T; Secord, AA; Zhou, C; Bae-Jump, V
Published in: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
April 15, 2021
Duke Scholars
Published In
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
ISSN
0392-2936
Publication Date
April 15, 2021
Volume
42
Issue
2
Start / End Page
387 / 388
Related Subject Headings
- Oncology & Carcinogenesis
- 3214 Pharmacology and pharmaceutical sciences
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Buckingham, L., O’Donnell, J., Hao, T., Secord, A. A., Zhou, C., & Bae-Jump, V. (2021). Ipatasertib, an oral AKT inhibitor, effectively inhibits cell proliferation and migration, and induces apoptosis in endometrioid and serous endometrial cancer cell lines in vitro (Endometrial Cancer Molecularly Targeted Therapy Consortium). In EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY (Vol. 42, pp. 387–388).
Buckingham, Lindsey, Jillian O’Donnell, Tianran Hao, Angeles Alvarez Secord, Chunxiao Zhou, and Victoria Bae-Jump. “Ipatasertib, an oral AKT inhibitor, effectively inhibits cell proliferation and migration, and induces apoptosis in endometrioid and serous endometrial cancer cell lines in vitro (Endometrial Cancer Molecularly Targeted Therapy Consortium).” In EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 42:387–88, 2021.
Buckingham L, O’Donnell J, Hao T, Secord AA, Zhou C, Bae-Jump V. Ipatasertib, an oral AKT inhibitor, effectively inhibits cell proliferation and migration, and induces apoptosis in endometrioid and serous endometrial cancer cell lines in vitro (Endometrial Cancer Molecularly Targeted Therapy Consortium). In: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. 2021. p. 387–8.
Buckingham, Lindsey, et al. “Ipatasertib, an oral AKT inhibitor, effectively inhibits cell proliferation and migration, and induces apoptosis in endometrioid and serous endometrial cancer cell lines in vitro (Endometrial Cancer Molecularly Targeted Therapy Consortium).” EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol. 42, no. 2, 2021, pp. 387–88.
Buckingham L, O’Donnell J, Hao T, Secord AA, Zhou C, Bae-Jump V. Ipatasertib, an oral AKT inhibitor, effectively inhibits cell proliferation and migration, and induces apoptosis in endometrioid and serous endometrial cancer cell lines in vitro (Endometrial Cancer Molecularly Targeted Therapy Consortium). EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. 2021. p. 387–388.
Published In
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
ISSN
0392-2936
Publication Date
April 15, 2021
Volume
42
Issue
2
Start / End Page
387 / 388
Related Subject Headings
- Oncology & Carcinogenesis
- 3214 Pharmacology and pharmaceutical sciences
- 3211 Oncology and carcinogenesis